company said that its distribution was "legally compliant," and that their restrictions did "prohibit resale to correctional facilities for use in lethal injections." Products Generic Medicines Branded Medicines Management Heather Bresch was an Executive Director and the CEO of Mylan from 2012 until the Viatris combination in 2020. Robert Coury was Chairman, and Rajiv Malik was President. References External links Tax inversions Defunct pharmaceutical companies of the United States Pharmaceutical companies established in 1961 Pharmaceutical companies disestablished in 2020 1961 establishments in West Virginia 2020 disestablishments in West Virginia Life sciences industry Generic drug manufacturers Health care companies of the United Kingdom Companies formerly listed on the New York Stock Exchange Companies formerly listed on the Nasdaq 1970s initial public offerings Canonsburg, Pennsylvania Companies based in Washington County, Pennsylvania Health care companies based in Pennsylvania 2020 mergers and acquisitions